Sex differences in the efficacy of glucagon-like peptide-1 receptor agonists for weight reduction: A systematic review and meta-analysis
Thanks to interesting ETF product development, especially in the past year, it could also mean a chance to consider the investment opportunity in weight loss as a theme
A healthy gut microbiome with diversity produces short-chain fatty acids, causing GLP-1 release
Temperature is a key determinate of how quickly food can be digested and leave the gastrointestinal tract
Visit HealthVerity Marketplace to access robust, real-world data on GLP-1 therapies and other high-impact drugs
GLP-1s are shaping how people eat, drink, shop, and exercise, and brands need to be paying close attention to these trends. Also referencing the KFF survey, Shil Kothari, president at Gateway Health Alliances Inc., Fairfield, Calif., explains that the awareness of GLP-1s mean that beverage manufacturers must play a proactive role in offering solutions that support those using these medications